Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/30/2012US20120220661 Methods of modulation of branched chain acids and uses thereof
08/30/2012US20120220660 Composition With Preventive or Improvement Effect on Symptoms or Diseases Associated with Stress-Induced Behavior Disorders
08/30/2012US20120220659 Medicament having promoting action on hepatocyte proliferation
08/30/2012US20120220658 Method for Treating Sepsis or Septic Shock
08/30/2012US20120220657 Synergistic anti-inflammatory and antioxidant dietary supplement compositions
08/30/2012US20120220656 Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease
08/30/2012US20120220655 Crystalline forms of fesoterodine fumarate and fesoterodine base
08/30/2012US20120220654 Therapeutic solution concentrate
08/30/2012US20120220652 Synthetic Triterpenoids and Methods of Use in the Treatment of Disease
08/30/2012US20120220651 Desferrioxamine-metal complexes for the treatment of immune-related disorders
08/30/2012US20120220650 Functional microbially fermented tea extract containing polyphenol derivative and method for producing the same
08/30/2012US20120220649 Modified double-stranded polynucleotide
08/30/2012US20120220648 Method of Treating Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Using Adeno-Associated Virus (AAV)-AADC Vector
08/30/2012US20120220647 Nano-hybrid of targetable sirna-layered inorganic hydroxide, manufacturing method thereof, and pharmaceutical composition for treating tumor comprising the nano-hybrid
08/30/2012US20120220646 Treatment of Cancer by Inhibition of IGFBPs and Clusterin
08/30/2012US20120220645 Genetic changes in atm and atr/chek1 as prognostic indicators in cancer
08/30/2012US20120220644 Use of two microrna moleculars in lung cancer prognosis and medicine preparation
08/30/2012US20120220643 Amino Acid Compounds
08/30/2012US20120220642 Amino Acid Compounds
08/30/2012US20120220641 Laser enhanced amino acid blend and use of same to regenerate active myocardial tissue
08/30/2012US20120220640 Methods of treating diseases
08/30/2012US20120220639 Rhodacyanine derivative and pharmaceutical composition for treating leishmaniasis
08/30/2012US20120220637 Ophthalmologic Compositions And Use Mode Thereof
08/30/2012US20120220636 Pharmaceutical composition for the treatment of mcp-1 mediated inflammatory diseases
08/30/2012US20120220635 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
08/30/2012US20120220634 Taxane Compounds, Compositions And Methods
08/30/2012US20120220633 Piperidine derivatives as human papilloma virus inhibitors
08/30/2012US20120220632 Methods For Treatment of Fabry Disease
08/30/2012US20120220631 USE OF 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AS TUMOR NECROSIS FACTOR INHIBITOR
08/30/2012US20120220630 Prucalopride oral solution
08/30/2012US20120220629 Asymmetric ureas and medical uses thereof
08/30/2012US20120220628 Tablets comprising a taste masking agent
08/30/2012US20120220627 Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
08/30/2012US20120220626 Novel quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease
08/30/2012US20120220625 Pharmaceutical composition and administrations thereof
08/30/2012US20120220624 Pyrazolo [3,4-b] pyridin-4-one kinase inhibitors
08/30/2012US20120220623 The enantiomer of tenatoprazole and the use thereof in therapy
08/30/2012US20120220622 Heterocyclic derivatives
08/30/2012US20120220621 Anti-cancer compound and pharmaceutical composition containing the same
08/30/2012US20120220620 Antitubercular alkaloid
08/30/2012US20120220619 Rapamycin Derivative or an Impdh Inhibitor for Treating Polycystic Kidney Disease
08/30/2012US20120220618 Anticancer agent sensitivity-determining marker
08/30/2012US20120220617 Fluorescent Perylene Derivatives for Direct Detection of Heparin
08/30/2012US20120220616 Novel spiropiperidine compounds
08/30/2012US20120220615 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
08/30/2012US20120220614 Substituted biaryl derivatives and methods of use thereof
08/30/2012US20120220613 Method for determining sensitivity to an anticancer agent
08/30/2012US20120220612 Pharmaceutical comprising ppar agonist
08/30/2012US20120220611 1,3-benzoxazolyl derivatives as kinase inhibitors
08/30/2012US20120220610 Inhibitions of glutaminase c
08/30/2012US20120220609 5-hydroxypyrimidine-4-carboxamide derivative
08/30/2012US20120220608 Method of preventing and treating hepatic disease using a2b adenosine receptor antagonists
08/30/2012US20120220607 Compositions and methods for treatment and prevention of hyperuricemia related health consequences
08/30/2012US20120220606 New capped pyrazinoylguanidine sodium channel blockers
08/30/2012US20120220605 Oxopiperazine derivatives for the treatment of pain and epilepsy
08/30/2012US20120220604 Piperazinyl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/30/2012US20120220603 Substituted heterocyclic derivatives for the treatment of pain and epilepsy
08/30/2012US20120220602 Cysteine protease inhibitors
08/30/2012US20120220601 Delta opioid receptor agonist compounds
08/30/2012US20120220600 N-Oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl) -1--1-methyl-urea
08/30/2012US20120220599 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
08/30/2012US20120220598 Besylate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4 Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6, 7-dihydro-5H-Pyrrolo[3,4-b]Pyrazine
08/30/2012US20120220597 L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine
08/30/2012US20120220596 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
08/30/2012US20120220595 Deuterated Tyrosine Kinase Inhibitors
08/30/2012US20120220594 Methods for treating cancer in patients having igf-1r inhibitor resistance
08/30/2012US20120220593 Substituted Acrylamide Derivative and Pharmaceutical Composition Comprising the Same
08/30/2012US20120220592 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
08/30/2012US20120220591 Pyrimidone compounds
08/30/2012US20120220590 Novel compounds as modulators of glucocorticoid receptors
08/30/2012US20120220589 Heterocyclic compounds for the inhibition of pask
08/30/2012US20120220588 Quinazoline compounds
08/30/2012US20120220587 Pyridinylimidazolone derivatives for the inhibition of pi3 kinases
08/30/2012US20120220586 Heterocyclic compounds and their uses
08/30/2012US20120220585 Heterocyclic compounds and their uses
08/30/2012US20120220584 Heterocyclic compounds and methods of use
08/30/2012US20120220583 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
08/30/2012US20120220582 Imidazopyrazine syk inhibitors
08/30/2012US20120220581 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
08/30/2012US20120220580 Preparation of carotenoid derivatives and their applications
08/30/2012US20120220579 Methods of utilizing arylpiperazine derivatives
08/30/2012US20120220578 Gum resin as a carrier for topical application of pharmacologically active agents
08/30/2012US20120220577 Glycine b antagonists
08/30/2012US20120220576 Novel Heterocyclic Derivatives
08/30/2012US20120220575 N-substituted oxazinopteridines and oxazinopteridinones
08/30/2012US20120220574 Methods of utilizing arylpiperazine derivatives
08/30/2012US20120220573 Benzodiazepine Bromodomain Inhibitor
08/30/2012US20120220572 Tricyclic inhibitors of kinases
08/30/2012US20120220571 Hiv integrase inhibitors
08/30/2012US20120220570 Fused heterocyclic ring derivative and use thereof
08/30/2012US20120220569 Fused heterocyclic ring derivative and use thereof
08/30/2012US20120220568 Histamine-3 Receptor Antagonists
08/30/2012US20120220567 Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
08/30/2012US20120220566 Antimicrobial Compounds and Methods of Making and Using the Same
08/30/2012US20120220565 Pyridyl-amine fused azadecalin modulators
08/30/2012US20120220564 Selective calcium channel modulators
08/30/2012US20120220563 Substituted piperidines
08/30/2012US20120220562 Anti-Viral Compounds
08/30/2012US20120220561 Oxadiazole inhibitors of leukotriene production
08/30/2012US20120220560 Steroid tetrol solid state forms
1 ... 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 ... 7860